Description
Develop a multiplex assay to measure the immune response to the nine prevalent HPV types.
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $134,700 at start, $199,884 after amendment #3 (+$65,184).
- #02019-06-24$134,700
- #12019-06-24$134,700
- #32020-11-04$199,884+$65,184
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2019-06-24(start date) | $134,700 | — | Develop a multiplex assay to measure the immune response to the nine prevalent HPV types. |
| #1 amendment | 2019-06-24 | $134,700 | +$0 | Develop a multiplex assay to measure the immune response to the nine prevalent HPV types. |
| #3 amendment | 2020-11-04 | $199,884 | +$65,184 | Develop a multiplex assay to measure the immune response to the nine prevalent HPV types. |
Related records · 8
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 738323518)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2021-2022-Q1-971679 | National Research Council Canada | Conseil national de recherches Canada · CanExport SMEs | $34,500 | FY2022 |
| 093-2020-2021-Q4-00176 | Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec · Regional Economic Growth through Innovation Program (REGI) | $2,000,000 | FY2021 |
| 064-2020-2021-Q1-00059 | Global Affairs Canada | Affaires mondiales Canada · CanExport Program | $11,023 | FY2020 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2019-2020-Q2-930181 · retrieved 2026-11-15.